Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison A Motsinger

Showing results (1-10 of 165) with videos related to

Pageof 17
Sort By:
BMC Research Notes|January 1, 2009
The effect of alternative permutation testing strategies on the performance of multifactor dimensionality reductionAlison A Motsinger-Reif
The Journal of Infectious Diseases|March 9, 2010
Discussion of a genome-wide association approach to determine HIV-1 set point in African AmericansAlison A Motsinger-Reif
Pharmacogenomics|January 20, 2012
A predictive model for efavirenz dosingChad Brown, Alison A Motsinger-Reif
Human Genomics|April 6, 2006
Multifactor dimensionality reduction: an analysis strategy for modelling and detecting gene-gene interactions in human genetics and pharmacogenomics studiesAlison A Motsinger, Marylyn D Ritchie
Frontiers in Genetics|July 27, 2013
Evaluation of genetic risk score models in the presence of interaction and linkage disequilibriumRonglin Che, Alison A Motsinger-Reif
Genetic Epidemiology|June 27, 2006
The effect of reduction in cross-validation intervals on the performance of multifactor dimensionality reductionAlison A Motsinger, Marylyn D Ritchie
Statistical Applications in Genetics and Molecular Biology|October 2, 2012
A new explained-variance based genetic risk score for predictive modeling of disease riskRonglin Che, Alison A Motsinger-Reif
Pharmacogenomics|February 25, 2012
Do genetic polymorphisms of nevirapine metabolic, transport and antigen recognition enzymes play a role in nevirapine toxicity risk?Gunjan Hariani, Alison A Motsinger-Reif
Pharmacogenomics|November 22, 2005
Multifactor dimensionality reduction for detecting gene-gene and gene-environment interactions in pharmacogenomics studiesMarylyn D Ritchie, Alison A Motsinger
Dose-Response : a Publication of International Hormesis Society|October 21, 2011
Optimization of nonlinear dose- and concentration-response models utilizing evolutionary computationAndrew L Beam, Alison A Motsinger-Reif
Pageof 17

Showing results (1-10 of 165) with videos related to

Sort By:
Pageof 17
BMC Research Notes|January 1, 2009
The effect of alternative permutation testing strategies on the performance of multifactor dimensionality reductionAlison A Motsinger-Reif
The Journal of Infectious Diseases|March 9, 2010
Discussion of a genome-wide association approach to determine HIV-1 set point in African AmericansAlison A Motsinger-Reif
Pharmacogenomics|January 20, 2012
A predictive model for efavirenz dosingChad Brown, Alison A Motsinger-Reif
Human Genomics|April 6, 2006
Multifactor dimensionality reduction: an analysis strategy for modelling and detecting gene-gene interactions in human genetics and pharmacogenomics studiesAlison A Motsinger, Marylyn D Ritchie
Frontiers in Genetics|July 27, 2013
Evaluation of genetic risk score models in the presence of interaction and linkage disequilibriumRonglin Che, Alison A Motsinger-Reif
Genetic Epidemiology|June 27, 2006
The effect of reduction in cross-validation intervals on the performance of multifactor dimensionality reductionAlison A Motsinger, Marylyn D Ritchie
Statistical Applications in Genetics and Molecular Biology|October 2, 2012
A new explained-variance based genetic risk score for predictive modeling of disease riskRonglin Che, Alison A Motsinger-Reif
Pharmacogenomics|February 25, 2012
Do genetic polymorphisms of nevirapine metabolic, transport and antigen recognition enzymes play a role in nevirapine toxicity risk?Gunjan Hariani, Alison A Motsinger-Reif
Pharmacogenomics|November 22, 2005
Multifactor dimensionality reduction for detecting gene-gene and gene-environment interactions in pharmacogenomics studiesMarylyn D Ritchie, Alison A Motsinger
Dose-Response : a Publication of International Hormesis Society|October 21, 2011
Optimization of nonlinear dose- and concentration-response models utilizing evolutionary computationAndrew L Beam, Alison A Motsinger-Reif
Pageof 17